Alias
科研级 Briakinumab ( 布雷奴单抗 ), Anti-IL12B Recombinant Antibody, Research Grade Briakinumab
Molecular Name
Briakinumab
Molecular Weight
146.5 kDa
Applications
FC, IP, ELISA, Neut, FuncS
Purity
≥95% as determined by SDS-PAGE
Buffer
Supplied in PBS, PH7.5
Protein Chemical Formula
C6376H9874N1722O1992S44
Target
IL12B[Homo sapiens]
Sequence
Please contact our sales representative to learn more information about this reagents.
Background
Briakinumab (ABT-874) is a human monoclonal antibody being developed by Abbott Laboratories for the treatment of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. As of 2011 drug development for psoriasis has been discontinued in the U.S. and Europe.
Storage
该产品可在 2°C-8°C 下保存一个月,活性不会明显降低。在 -20°C 至 -80°C 下保存,可稳定保存十二个月。避免反复冻融,用冰袋运输。